BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 27102153)

  • 1. Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.
    Liappas G; González-Mateo G; Aguirre AR; Abensur H; Albar-Vizcaino P; Parra EG; Sandoval P; Ramírez LG; Del Peso G; Acedo JM; Bajo MA; Selgas R; Sánchez Tomero JA; López-Cabrera M; Aguilera A
    Oncotarget; 2016 May; 7(21):30133-46. PubMed ID: 27102153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis.
    Loureiro J; Sandoval P; del Peso G; Gónzalez-Mateo G; Fernández-Millara V; Santamaria B; Bajo MA; Sánchez-Tomero JA; Guerra-Azcona G; Selgas R; López-Cabrera M; Aguilera AI
    PLoS One; 2013; 8(4):e61165. PubMed ID: 23637793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arctigenin alleviates TGF-β1-induced epithelial-mesenchymal transition and PAI-1 expression via AMPK/NF-κB pathway in peritoneal mesothelial cells.
    Jin G; Su Y; Dong Q; Zhao X; Zhang L; Yan X
    Biochem Biophys Res Commun; 2019 Dec; 520(2):413-419. PubMed ID: 31607474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
    Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage.
    Sandoval P; Loureiro J; González-Mateo G; Pérez-Lozano ML; Maldonado-Rodríguez A; Sánchez-Tomero JA; Mendoza L; Santamaría B; Ortiz A; Ruíz-Ortega M; Selgas R; Martín P; Sánchez-Madrid F; Aguilera A; López-Cabrera M
    Lab Invest; 2010 Oct; 90(10):1517-32. PubMed ID: 20531289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway.
    Zhang Y; Huang Q; Chen Y; Peng X; Wang Y; Li S; Wu J; Luo C; Gong W; Yin B; Xiao J; Zhou W; Peng F; Long H
    Int Immunopharmacol; 2020 Jan; 78():106064. PubMed ID: 31838448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion.
    Pletinck A; Van Landschoot M; Steppan S; Laukens D; Passlick-Deetjen J; Vanholder R; Van Biesen W
    Nephrol Dial Transplant; 2012 Feb; 27(2):548-56. PubMed ID: 21750165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to reconsider saline as the ideal rinsing solution during abdominal surgery.
    Połubinska A; Winckiewicz M; Staniszewski R; Breborowicz A; Oreopoulos DG
    Am J Surg; 2006 Sep; 192(3):281-5. PubMed ID: 16920418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
    Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
    Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C α inhibition prevents peritoneal damage in a mouse model of chronic peritoneal exposure to high-glucose dialysate.
    Wang L; Balzer MS; Rong S; Menne J; von Vietinghoff S; Dong L; Gueler F; Jang MS; Xu G; Timrott K; Tkachuk S; Hiss M; Haller H; Shushakova N
    Kidney Int; 2016 Jun; 89(6):1253-67. PubMed ID: 27142955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.
    Shi Y; Tao M; Wang Y; Zang X; Ma X; Qiu A; Zhuang S; Liu N
    J Pathol; 2020 Jan; 250(1):79-94. PubMed ID: 31579944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin Protects from Type-I Peritoneal Membrane Failure Inhibiting the Angiogenesis, Lymphangiogenesis, and Endo-MT.
    González-Mateo GT; Aguirre AR; Loureiro J; Abensur H; Sandoval P; Sánchez-Tomero JA; del Peso G; Jiménez-Heffernan JA; Ruiz-Carpio V; Selgas R; López-Cabrera M; Aguilera A; Liappas G
    Biomed Res Int; 2015; 2015():989560. PubMed ID: 26688823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis.
    Ferrantelli E; Liappas G; Vila Cuenca M; Keuning ED; Foster TL; Vervloet MG; Lopéz-Cabrera M; Beelen RH
    Kidney Int; 2016 Mar; 89(3):625-35. PubMed ID: 26880457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage.
    Loureiro J; Aguilera A; Selgas R; Sandoval P; Albar-Vizcaíno P; Pérez-Lozano ML; Ruiz-Carpio V; Majano PL; Lamas S; Rodríguez-Pascual F; Borras-Cuesta F; Dotor J; López-Cabrera M
    J Am Soc Nephrol; 2011 Sep; 22(9):1682-95. PubMed ID: 21742730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paricalcitol ameliorates epithelial-to-mesenchymal transition in the peritoneal mesothelium.
    Kang SH; Kim SO; Cho KH; Park JW; Yoon KW; Do JY
    Nephron Exp Nephrol; 2014; 126(1):1-7. PubMed ID: 24458092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of TGF-β1 Receptor Inhibitor GW788388 on the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells.
    Lho Y; Do JY; Heo JY; Kim AY; Kim SW; Kang SH
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy promotes fibrosis and apoptosis in the peritoneum during long-term peritoneal dialysis.
    Wu J; Xing C; Zhang L; Mao H; Chen X; Liang M; Wang F; Ren H; Cui H; Jiang A; Wang Z; Zou M; Ji Y
    J Cell Mol Med; 2018 Feb; 22(2):1190-1201. PubMed ID: 29077259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pathogenetic role for endothelin-1 in peritoneal dialysis-associated fibrosis.
    Busnadiego O; Loureiro-Álvarez J; Sandoval P; Lagares D; Dotor J; Pérez-Lozano ML; López-Armada MJ; Lamas S; López-Cabrera M; Rodríguez-Pascual F
    J Am Soc Nephrol; 2015 Jan; 26(1):173-82. PubMed ID: 25012164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WNT signaling is required for peritoneal membrane angiogenesis.
    Padwal M; Cheng G; Liu L; Boivin F; Gangji AS; Brimble KS; Bridgewater D; Margetts PJ
    Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1036-F1045. PubMed ID: 29363326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on mechanisms of ultrafiltration failure.
    Kim YL
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S123-7. PubMed ID: 19270200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.